Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity.
about
Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Comparison of first- and secon ...... ility, and regimen complexity.
@en
Comparison of first- and secon ...... ility, and regimen complexity.
@nl
type
label
Comparison of first- and secon ...... ility, and regimen complexity.
@en
Comparison of first- and secon ...... ility, and regimen complexity.
@nl
prefLabel
Comparison of first- and secon ...... ility, and regimen complexity.
@en
Comparison of first- and secon ...... ility, and regimen complexity.
@nl
P2093
P2860
P1476
Comparison of first- and secon ...... ility, and regimen complexity.
@en
P2093
Blaire E Burman
Kris V Kowdley
Paul Y Kwo
P2860
P2888
P304
P356
10.1007/S12072-014-9552-6
P577
2014-07-09T00:00:00Z